Arrowhead Pharmaceuticals, Inc. (ARWR)
58.16
+0.70
(+1.22%)
USD |
NASDAQ |
Nov 06, 16:00
58.14
-0.02
(-0.03%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Market Cap : 8.208B for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 8.208B |
| November 05, 2026 | 8.110B |
| November 04, 2026 | 8.701B |
| November 03, 2026 | 8.402B |
| November 02, 2026 | 8.407B |
| October 30, 2026 | 8.454B |
| October 29, 2026 | 8.537B |
| October 28, 2026 | 8.498B |
| October 27, 2026 | 8.331B |
| October 26, 2026 | 8.324B |
| October 23, 2026 | 8.189B |
| October 22, 2026 | 8.237B |
| October 21, 2026 | 8.304B |
| October 20, 2026 | 8.316B |
| October 19, 2026 | 8.077B |
| October 16, 2026 | 7.889B |
| October 15, 2026 | 8.256B |
| October 14, 2026 | 8.238B |
| October 13, 2026 | 8.204B |
| October 12, 2026 | 8.571B |
| October 09, 2026 | 8.856B |
| October 08, 2026 | 8.573B |
| October 07, 2026 | 8.677B |
| October 06, 2026 | 8.685B |
| October 05, 2026 | 8.800B |
| Date | Value |
|---|---|
| October 02, 2026 | 9.059B |
| October 01, 2026 | 9.144B |
| September 30, 2026 | 9.237B |
| September 29, 2026 | 9.350B |
| September 28, 2026 | 9.239B |
| September 25, 2026 | 9.304B |
| September 24, 2026 | 9.325B |
| September 23, 2026 | 9.450B |
| September 22, 2026 | 10.14B |
| September 21, 2026 | 9.709B |
| September 18, 2026 | 9.383B |
| September 17, 2026 | 9.560B |
| September 16, 2026 | 9.285B |
| September 15, 2026 | 9.974B |
| September 14, 2026 | 11.39B |
| September 11, 2026 | 11.69B |
| September 10, 2026 | 11.68B |
| September 09, 2026 | 11.66B |
| September 08, 2026 | 12.01B |
| September 04, 2026 | 12.19B |
| September 03, 2026 | 12.21B |
| September 02, 2026 | 12.05B |
| September 01, 2026 | 11.68B |
| August 31, 2026 | 11.63B |
| August 28, 2026 | 11.98B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 101.42B |
| Sarepta Therapeutics, Inc. | 1.882B |
| Twist Bioscience Corp. | 7.570B |
| Revolution Medicines, Inc. | 41.58B |
| Immunome, Inc. | 2.122B |
Market Cap Related Metrics
| PS Ratio | 12.21 |
| PEG Ratio | -0.3344 |
| Price to Book Value | 17.63 |
| Price | 58.16 |
| Earnings Yield | -3.86% |
| PEGY Ratio | -0.3344 |